Pain News and Research

Latest Pain News and Research

How to recognize heart attack symptoms in younger women

The risk for heart-related death is increasing in young adults ages 35 to 54, and the numbers are even more alarming for younger women. It is the number-one cause of death for both men and women in the United States, yet every year since 1984 more women have died of cardiovascular health problems than men, according to the American Heart Association.

29 Jan 2010

NHMRC awards Development Grant to speed up chronic wound treatment

A new treatment that could one day benefit burns victims, diabetes sufferers and the elderly - by fast tracking the healing of chronic wounds - has taken another step towards commercialization.

29 Jan 2010

Arthritis pain relief drug ALEVE now available OTC in British Columbia

This winter, British Columbians may be inspired to increase their activity level and take part in some favourite winter pastimes. For those who have joint and arthritis pain, getting back to doing the activities they love may be more of a challenge. ALEVE(R) is the first over-the-counter naproxen sodium tablet, and is now available province-wide. With just one pill, ALEVE(R) offers convenient access to pain relief for up to 12 hours.

29 Jan 2010

APF survey reveals breakthrough cancer pain causes medical and financial hardships for cancer patients

A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.

29 Jan 2010

OMT, a viable option for treating back pain in the third trimester of pregnancy

For many pregnant women, it's inevitable. As their pregnancy progresses, tasks that involve the low back often get more difficult. It is harder to bend over, lift, sit or walk for long periods of time, and back pain increases. Treating back pain, and improving daily function relative to tasks that involve the low back is a challenge because pregnant women are limited to treatments that will not create problems for their developing baby.

29 Jan 2010

AccuDial Pharmaceutical introduces eight new OTC medications in Canada

AccuDial® Pharmaceutical, Inc. delivered a power-packed launch with their new family of eight over-the-counter (OTC) medications in Canada. Colorful floor displays enjoyed prominent placement in every Quebec Walmart pharmacy, and were filled with AccuDial's pain and fever, allergy, and cough and cold pediatric medications.

29 Jan 2010

RTI Biologics donates Matrix HD to treat eight-year-old with recessive dystrophic EB

RTI Biologics Inc. (RTI), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated a sterilized dermis allograft, Matrix HD™, to treat an eight-year old patient with a rare skin disease called recessive dystrophic epidermolysis bullosa (EB).

29 Jan 2010

Study shows doctors cut back their workload for fear of malpractice lawsuits

A new study shows that the number of hours physicians spend on the job each week is influenced by the fear of malpractice lawsuits.

29 Jan 2010

New technique could eliminate hip replacement surgeries in young trauma patients

A novel surgery using transplanted bone and cartilage may help young patients avoid a hip replacement after a specific traumatic injury to the hip joint, according to a case study by orthopedic trauma specialists at Hospital for Special Surgery in New York. The study appears in the February issue of the Journal of Orthopaedic Trauma.

28 Jan 2010

Aubrey receives FDA clearance to market bioengineered wound dressings in U.S.

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.

28 Jan 2010

DNA variations in genes increase risk of developing PI-IBS

Studies of the victims of the Walkerton, Ont. tainted drinking water tragedy have led researchers to discover DNA variations in genes that increase the risk of developing post-infectious irritable bowel syndrome (PI-IBS). The sheer scale of infection and the recording of the health of Walkerton's citizens gave a team of researchers a unique opportunity to study the origin of this disorder.

28 Jan 2010

Palliative care program may complement patients' ongoing care with symptom management and support

Georgia Sue Huston knew she was really sick. Every time the 82-year-old woman tried to turn over in her bed in the coronary care unit at Stanford Hospital & Clinics, she’d panic because she couldn’t get enough air and because it hurt so much.

28 Jan 2010

Workers' compensation status may affect treatment outcomes for herniated disks

Surgery provides better results than nonsurgical treatment for most patients with back pain related to a herniated disk—but not for those receiving workers' compensation for work-related injuries, reports a study in the January 1 issue of Spine.

28 Jan 2010

Onset Therapeutics expands its sales force to create nationwide presence

Onset Therapeutics LLC, a specialty pharmaceutical company focused in dermatology, today announced that the Company’s recent growth and future opportunities have facilitated an expansion of its field sales organization to cover more than twenty-five additional major metropolitan areas.

28 Jan 2010

Automated measurements more reliable in moderate cases of knee degeneration

Scientists have automated the measurement of a vital part of the knee in images with a computer program that performs much faster and just as reliably as humans who interpret the same images.

28 Jan 2010

Pfizer's new pipeline shows growth and diversity in research and development

Pfizer Inc. today provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October, 2009. The new development pipeline, composed of assets from both legacy companies, includes 133 programs from phase 1 through registration, and shows growth and increased diversity in each of the areas where the company invests in research and development.

28 Jan 2010

New scientific data reveals wood pallets present dangerous risks to our foods and medicines

Coming on the heels of the sweeping Tylenol recall, new scientific data from independent tests reveal more about the hidden dangers of wood pallets and the threat they pose to the foods we eat and the medications we rely on every day.

28 Jan 2010

Merck receives marketing authorization for ELONVA

Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

28 Jan 2010

Braces and supports can help prevent injury while gardening

Women risk any number of strains, sprains, and injuries while working in their gardens, but by using braces designed specifically for women’s bodies such as the ones made by Wellgate for Women, women are able to help reduce their pain and support their joints while still enjoying all the peace and relaxation that a garden brings.

28 Jan 2010

Spine Pain Management announces revenue guidance for the fourth-quarter and year ending Dec. 31, 2009

Spine Pain Management, Inc., through its Chairman/CEO Dr. William Donovan, today issued revenue guidance for the fourth quarter and year ending Dec. 31, 2009. Spine Pain Management, Inc. began operations of its first clinic in Houston, TX late September 2009. Revenues for the three months ending Dec. 31, 2009 were approximately $730,000.

28 Jan 2010